论文部分内容阅读
目的:探讨利巴韦林雾化吸入联合蒲地蓝消炎口服液治疗疱疹性口炎的临床疗效。方法:将我科2009年5月-2010年5月收治的80例疱疹性口炎患儿随机分为观察组和对照组各40例,观察组给予利巴韦林雾化吸入联合蒲地蓝消炎口服液治疗,对照组给予对症治疗。观察2组临床疗效和不良反应。结果:观察组显效率及总有效率明显高于对照组,2组相比差异有极显著性(P<0.01)。结论:利巴韦林雾化吸入联合蒲地蓝消炎口服液治疗疱疹性口炎疗程短、见效快、安全可靠,值得临床推广应用。
Objective: To investigate the clinical efficacy of ribavirin aerosol inhalation combined with Pudicam anti-inflammatory oral liquid in the treatment of herpetic stomatitis. Methods: 80 cases of herpes stomatitis admitted to our department from May 2009 to May 2010 were randomly divided into observation group and control group, 40 cases in each group. The observation group was treated with ribavirin aerosol inhalation combined with defensive blue Oral liquid treatment, the control group given symptomatic treatment. The clinical effects and adverse reactions in 2 groups were observed. Results: The effective rate and total effective rate in the observation group were significantly higher than those in the control group. There was significant difference between the two groups (P <0.01). Conclusion: Ribavirin aerosol inhalation combined with Pudicam anti-inflammatory oral solution for herpetic stomatitis treatment is short, quick, safe and reliable, worthy of clinical application.